Product Data Sheet

KRAS G12C inhibitor 18

Catalog No. A63607

main product photo
KRAS G12C inhibitor 18 is a selective inhibitor targeting the KRAS G12C mutation. This compound exhibits significant anti-tumor activity, making it valuable for cancer research focused on KRAS-driven malignancies. It is suitable for studies investigating the therapeutic potential of KRAS inhibition in oncogenesis and treatment resistance.
Chemical Information
Catalog NumA63607
M. Wt510.97
FormulaC25H20ClFN4O3S
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2649788-45-2
Synonyms
SMILESN#CC1=C(N)SC2=CC=CC(C3=C(F)C=C(C(N4[C@@](CN(CC4)C(C=C)=O)([H])CCO5)=O)C5=C3Cl)=C12
Biological Activity
DescriptionKRAS G12C inhibitor 18 is a selective inhibitor targeting the KRAS G12C mutation. This compound exhibits significant anti-tumor activity, making it valuable for cancer research focused on KRAS-driven malignancies. It is suitable for studies investigating the therapeutic potential of KRAS inhibition in oncogenesis and treatment resistance.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.